2.1 Sample Collection, Anticoagulants, Integrity & Stability

Pre-Analytical Standardization in Flow Cytometry

The pre-analytical phase accounts for up to 70% of errors in clinical and diagnostic laboratory testing. In flow cytometry, sample integrity dictates data quality. Because flow cytometric analysis relies on single-cell suspensions interrogating intact physical and fluorescent parameters, any pre-analytical degradation—such as cellular lysis, microaggregation, surface receptor shedding, or non-specific artifactual staining—irreversibly compromises analytical resolution. Establishing standardized protocols for specimen collection, anticoagulant selection, transport conditions, and rejection criteria is the foundational requirement for accurate immunophenotyping, leukemia/lymphoma diagnostics, and functional cellular assays.

Anticoagulants: Biochemical Mechanisms and Applications

The choice of anticoagulant profoundly influences cell viability, membrane receptor stability, and downstream assay compatibility. The three primary anticoagulants utilized in cytometry are K2/K3 EDTA, Sodium Heparin, and Acid Citrate Dextrose (ACD).

K2/K3 EDTA (Ethylenediaminetetraacetic Acid)

EDTA functions as a potent chelator of divalent cations, specifically calcium (Ca2+) and magnesium (Mg2+). By removing free calcium required for the coagulation cascade, EDTA rapidly halts clot formation.

• Primary Indications: EDTA is the standard, globally accepted anticoagulant for routine peripheral blood and bone marrow immunophenotyping, absolute CD4/CD8 T-cell counting, and leukemia/lymphoma panel analysis.
• Advantages: EDTA effectively prevents platelet activation and clumping, minimizing platelet-leukocyte satellitism that can cause false-positive gating errors in monocyte and lymphocyte gates.
• Limitations: Because EDTA deprives cells of extracellular Ca2+, it cannot be used for functional assays requiring calcium signaling (e.g., intracellular calcium flux upon TCR stimulation). Furthermore, Ca2+-dependent binding assays—such as Annexin V apoptosis staining, which requires extracellular calcium to bind phosphatidylserine—will fail in the presence of residual EDTA.

Sodium Heparin

Heparin acts indirectly by binding to and accelerating the activity of antithrombin III, which inactivates thrombin, Factor Xa, and related serine proteases in the clotting cascade.

• Primary Indications: Heparin is the anticoagulant of choice for functional immunologic assays, including T-cell proliferation assays, intracellular cytokine staining (ICS), Natural Killer (NK) cell cytotoxicity, and cell culture studies.
• Advantages: Heparin does not chelate divalent cations, preserving endogenous cellular metabolism, enzyme function, and signaling cascades.
• Limitations: Heparin can induce platelet activation and microaggregate formation. Platelet-leukocyte aggregates alter forward and side scatter characteristics, making monocyte and granulocyte resolution difficult. In addition, heparin can cause non-specific binding of certain cationic fluorochromes and inhibits PCR amplification enzymes if downstream molecular testing is required.

Acid Citrate Dextrose (ACD)

ACD solutions (Solution A and Solution B) contain trisodium citrate, citric acid, and dextrose. Citrate acts as a reversible calcium chelator, while dextrose supplies a metabolic energy source for cellular glycolysis.

• Primary Indications: ACD is preferred for specimens requiring prolonged transport times (>24–48 hours), HLA tissue typing, fragile cell populations, and pediatric samples.
• Advantages: The dextrose component maintains intracellular ATP levels, preserving membrane integrity, cell viability, and surface marker expression significantly longer than EDTA or Heparin alone.
• Limitations: Citrate causes mild cell dilution and osmotic fluid shifts that slightly alter baseline forward light scatter (FSC) properties.

Storage Temperature and Transport Protocols

Maintaining proper environmental conditions during specimen handling is essential to prevent artifactual cell death and phenotype alteration.

Temperature Management

• Room Temperature (18–22°C): Whole blood and bone marrow specimens for routine immunophenotyping MUST be stored and transported at room temperature.
• Contraindication of Chilling (2–8°C): Storing un-fixed blood at refrigerated temperatures (2–8°C) causes rapid activation and degranulation of neutrophils/granulocytes, resulting in heavy autolytic enzyme release, altered side scatter (SSC) profiles, and selective shedding of labile surface molecules such as L-selectin (CD62L). Cold storage also promotes irreversible platelet aggregation.
• Extreme Temperatures: Samples must never be frozen prior to cell processing or exposed to temperatures exceeding 37°C, as thermal stress induces rapid protein denaturation and cell membrane rupture.

Transport Stability Thresholds

• Peripheral Blood: Should ideally be processed within 24 hours of collection. Validated EDTA samples remain stable for routine immunophenotyping up to 48 hours at room temperature.
• Bone Marrow Aspirates: Highly susceptible to rapid cell death due to microenvironmental deprivation. Bone marrow should be processed within 24–48 hours and collected in transport media (e.g., RPMI-1640 supplemented with 10% fetal bovine serum and preservative-free heparin) if transport exceeds 12 hours.
• Body Fluids (CSF, Pleural, Ascitic): Contain low protein content and high proteolytic enzyme activity. Must be collected in protein-stabilized media (RPMI + 20% albumin) and analyzed within 6 hours of aspiration.

Specimen Rejection Criteria

Flow cytometry laboratories must enforce rigid rejection criteria to prevent inaccurate diagnostic reporting:

1. Macroscopic Clots: Clotted samples must be rejected. Fibrin mesh selectively traps large cells (monocytes, blasts) and alters relative subset percentages.
2. Severe Hemolysis: Indicates widespread red blood cell and leukocyte membrane destruction, releasing free hemoglobin and cellular debris that elevate optical background noise.
3. Incorrect Anticoagulant or Volume: Under-filled tubes alter the blood-to-anticoagulant ratio; hypertonic EDTA concentrations cause cell shrinkage and altered FSC.
4. Expired Stability Limits: Unvalidated specimens exceeding 48 hours (blood) or 72 hours (marrow) exhibit high baseline cell death (>20-30% dead cells), causing non-specific antibody binding and loss of diagnostic target populations.